S-1/A: Banzai International Files Amendment No. 1 to S-1 Registration Statement for Potential Resale of 25 Million Shares
S-1/A Amendment
Banzai International amends its registration statement to revise disclosures related to the potential resale of up to 25 million Class A Common Stock shares by a selling securityholder.
Summary
- Banzai International, Inc. has filed an amendment to its S-1 registration statement to revise certain disclosures in response to SEC comments.
- The registration statement concerns the potential offer and sale of up to 25,000,000 shares of Class A Common Stock by a selling securityholder.
- These shares are issuable pursuant to a standby equity purchase agreement (SEPA) with YA II PN, LTD (Yorkville).
- Banzai will not receive any proceeds from the sale of these shares.
- The company's Class A Common Stock is listed on The Nasdaq Global Market under the symbol BNZI.
- On September 24, 2024, the last reported sale price of the Class A Common Stock was $8.24 per share.
- Banzai had a hearing before The Nasdaq Hearings Panel on September 19, 2024, which stayed the suspension of trading on the company's securities.
- There is no assurance that the Panel will grant the Company an additional extension period or that the Company will ultimately regain compliance with all applicable requirements for continued listing on The Nasdaq Global Market.
- The company is an emerging growth company and has elected to comply with certain reduced public disclosure requirements.
Sentiment
Score: 5
Explanation: The document is neutral in tone, primarily providing factual information about the registration statement and related agreements. The risks associated with the potential stock sales are noted, balancing the overall sentiment.
Negatives
- Banzai will not receive any proceeds from the sale of shares of Class A Common Stock by the Selling Securityholder.
- Sales of a substantial number of shares of Class A Common Stock in the public market, including the resale of the shares of Class A Common Stock held by our stockholders pursuant to this prospectus or pursuant to Rule 144, could occur at any time.
- These sales, or the perception in the market that the holders of a large number of shares of Class A Common Stock intend to sell shares, could reduce the market price of the Class A Common Stock and make it more difficult for you to sell your holdings at times and prices that you determine are appropriate.
- We expect that, because there is a large number of shares being registered pursuant to the registration statement of which this prospectus forms a part, the Selling Securityholder will continue to offer the securities covered thereby pursuant to this prospectus or pursuant to Rule 144 for a significant period of time, the precise duration of which cannot be predicted.
- Accordingly, the adverse market and price pressures resulting from an offering pursuant to the registration statement may continue for an extended period of time.
- There can be no assurance that the Panel will grant the Company an additional extension period or that the Company will ultimately regain compliance with all applicable requirements for continued listing on The Nasdaq Global Market.
Risks
- Sales of a substantial number of shares of Class A Common Stock in the public market, including the resale of the shares of Class A Common Stock held by our stockholders pursuant to this prospectus or pursuant to Rule 144, could occur at any time.
- These sales, or the perception in the market that the holders of a large number of shares of Class A Common Stock intend to sell shares, could reduce the market price of the Class A Common Stock and make it more difficult for you to sell your holdings at times and prices that you determine are appropriate.
- We expect that, because there is a large number of shares being registered pursuant to the registration statement of which this prospectus forms a part, the Selling Securityholder will continue to offer the securities covered thereby pursuant to this prospectus or pursuant to Rule 144 for a significant period of time, the precise duration of which cannot be predicted.
- Accordingly, the adverse market and price pressures resulting from an offering pursuant to the registration statement may continue for an extended period of time.
- There can be no assurance that the Panel will grant the Company an additional extension period or that the Company will ultimately regain compliance with all applicable requirements for continued listing on The Nasdaq Global Market.
Future Outlook
The Selling Securityholder will continue to offer the securities covered thereby pursuant to this prospectus or pursuant to Rule 144 for a significant period of time, the precise duration of which cannot be predicted.
Industry Context
This announcement is related to the capital markets activity of Banzai International, specifically regarding the potential resale of shares acquired through a SEPA. It reflects the company's ongoing efforts to manage its capital structure and maintain its listing on the Nasdaq.
Stakeholder Impact
- Existing shareholders may experience dilution and potential downward pressure on the stock price due to the potential resale of a large number of shares.
- The company's ability to raise capital in the future may be affected by the market's perception of the potential stock sales.
- The company's continued listing on Nasdaq is subject to the Panel's decision, which could impact investor confidence.
Next Steps
- The Selling Securityholder may offer, sell or distribute all or a portion of their shares of Class A Common Stock publicly or through private transactions at prevailing market prices or at negotiated prices.
- The Company will pay the expenses, other than underwriting discounts and commissions and expenses incurred by the Selling Securityholder for brokerage, accounting, tax or legal services or any other expenses incurred by the Selling Securityholder in disposing of the securities, associated with the sale of securities pursuant to this prospectus.
- The Company will continue to seek compliance with Nasdaq listing requirements.
Key Dates
| Date | Description |
|---|---|
| 2020-12-22 | Date of the Warrant Agreement between 7GC and Continental Stock Transfer & Trust Company. |
| 2022-12-08 | Date of the Original Merger Agreement between Banzai and 7GC. |
| 2023-08-04 | Date of the Merger Agreement Amendment between Banzai and 7GC. |
| 2023-12-14 | Date of the Original SEPA between Banzai and Yorkville. |
| 2023-12-14 | Closing date of the Business Combination. |
| 2023-12-29 | Date Banzai filed a registration statement on Form S-1 (File No. 333-276307) with the SEC. |
| 2024-02-02 | Date the registration statement on Form S-1 (File No. 333-276307) was declared effective. |
| 2024-02-05 | Date of the SEPA Supplemental Agreement between Banzai and Yorkville. |
| 2024-05-22 | Date Banzai priced a best efforts public offering. |
| 2024-05-22 | Date Banzai and Yorkville entered into an Amended and Restated Debt Repayment Agreement. |
| 2024-05-28 | Date the best efforts public offering closed. |
| 2024-08-06 | Date Banzai received a written notice from Nasdaq regarding failure to comply with the MVLS requirement. |
| 2024-09-10 | Date Banzai's Board determined to effect a reverse stock split at a ratio of 1-for-50. |
| 2024-09-19 | Expected effective date of the reverse stock split. |
| 2024-09-19 | Date of Banzai's hearing before The Nasdaq Hearings Panel. |
| 2024-09-24 | Last reported sale price of Banzai's Class A Common Stock was $8.24 per share. |
| 2024-09-25 | Date of this prospectus. |
Keywords
Class A Common Stock, registration statement, SEPA, Yorkville, resale, shares, Banzai, offering, SEC, stock
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.